182 related articles for article (PubMed ID: 26687639)
41. Brain-derived neurotrophic factor (BDNF) levels in panic disorder: A systematic review and meta-analysis.
Shafiee A; Jafarabady K; Mohammadi I; Rajai S
Brain Behav; 2024 Jan; 14(1):e3349. PubMed ID: 38376041
[TBL] [Abstract][Full Text] [Related]
42. BDNF Val66Met polymorphism, life stress and depression: A meta-analysis of gene-environment interaction.
Zhao M; Chen L; Yang J; Han D; Fang D; Qiu X; Yang X; Qiao Z; Ma J; Wang L; Jiang S; Song X; Zhou J; Zhang J; Chen M; Qi D; Yang Y; Pan H
J Affect Disord; 2018 Feb; 227():226-235. PubMed ID: 29102837
[TBL] [Abstract][Full Text] [Related]
43. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample.
Strauss J; Barr CL; George CJ; Devlin B; Vetró A; Kiss E; Baji I; King N; Shaikh S; Lanktree M; Kovacs M; Kennedy JL
Mol Psychiatry; 2005 Sep; 10(9):861-7. PubMed ID: 15940299
[TBL] [Abstract][Full Text] [Related]
44. Effects of BDNF Val66Met Polymorphism on White Matter Microalterations of the Corpus Callosum in Patients with Panic Disorder in Korean Populations.
Kim HJ; Bang M; Lee KS; Choi TK; Park CI; Lee SH
Psychiatry Investig; 2020 Oct; 17(10):967-975. PubMed ID: 33017888
[TBL] [Abstract][Full Text] [Related]
45. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
[TBL] [Abstract][Full Text] [Related]
46. Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis.
Wang Y; Li O; Li N; Sha Z; Zhao Z; Xu J
Front Psychiatry; 2023; 14():1143833. PubMed ID: 37415688
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the Relationship Between
Mei S; Chen W; Chen S; Hu Y; Dai X; Liu X
Front Psychiatry; 2022; 13():888774. PubMed ID: 35573386
[TBL] [Abstract][Full Text] [Related]
48. The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.
Notaras M; Hill R; van den Buuse M
Mol Psychiatry; 2015 Aug; 20(8):916-30. PubMed ID: 25824305
[TBL] [Abstract][Full Text] [Related]
49. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
Notaras M; Hill R; van den Buuse M
Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
[TBL] [Abstract][Full Text] [Related]
50. An association between BDNF Val66Met polymorphism and impulsivity in methamphetamine abusers.
Su H; Tao J; Zhang J; Xie Y; Sun Y; Li L; Xu K; Han B; Lu Y; Sun H; Wei Y; Wang Y; Zhang Y; Zou S; Wu W; Zhang J; Zhang X; He J
Neurosci Lett; 2014 Oct; 582():16-20. PubMed ID: 25168604
[TBL] [Abstract][Full Text] [Related]
51. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis.
Kawashima K; Ikeda M; Kishi T; Kitajima T; Yamanouchi Y; Kinoshita Y; Okochi T; Aleksic B; Tomita M; Okada T; Kunugi H; Inada T; Ozaki N; Iwata N
Schizophr Res; 2009 Jul; 112(1-3):72-9. PubMed ID: 19406621
[TBL] [Abstract][Full Text] [Related]
52. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
[TBL] [Abstract][Full Text] [Related]
53. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
54. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
Hwang JP; Tsai SJ; Hong CJ; Yang CH; Lirng JF; Yang YM
Neurobiol Aging; 2006 Dec; 27(12):1834-7. PubMed ID: 16343697
[TBL] [Abstract][Full Text] [Related]
55. BDNF Val66Met and clinical response to antipsychotic drugs: A systematic review and meta-analysis.
Cargnin S; Massarotti A; Terrazzino S
Eur Psychiatry; 2016 Mar; 33():45-53. PubMed ID: 26854986
[TBL] [Abstract][Full Text] [Related]
56. The Brain-Derived Neurotrophic Factor Val66Met Polymorphism, Delivery Method, Birth Weight, and Night Sleep Duration as Determinants of Obesity in Vietnamese Children of Primary School Age.
Tuyet LT; Nhung BT; Dao DTA; Hanh NTH; Tuyen LD; Binh TQ; Thuc VTM
Child Obes; 2017 Oct; 13(5):392-399. PubMed ID: 28471701
[TBL] [Abstract][Full Text] [Related]
57. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
58. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis.
Blanco Y; Gómez-Choco M; Arostegui JL; Casanova B; Martínez-Rodríguez JE; Boscá I; Munteis E; Yagüe J; Graus F; Saiz A
Neurosci Lett; 2006 Apr; 396(3):217-9. PubMed ID: 16356643
[TBL] [Abstract][Full Text] [Related]
59. BDNF val66met genotype and schizotypal personality traits interact to influence probabilistic association learning.
Skilleter AJ; Weickert CS; Moustafa AA; Gendy R; Chan M; Arifin N; Mitchell PB; Weickert TW
Behav Brain Res; 2014 Nov; 274():137-42. PubMed ID: 25125238
[TBL] [Abstract][Full Text] [Related]
60. BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm.
Siokas V; Kardaras D; Aloizou AM; Asproudis I; Boboridis KG; Papageorgiou E; Hadjigeorgiou GM; Tsironi EE; Dardiotis E
Neuromolecular Med; 2019 Mar; 21(1):68-74. PubMed ID: 30519954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
